Overexpression of galectin2 (LGALS2) predicts a better prognosis in human breast cancer

CONCLUSION: In conclusion, LGALS2 has potential as a valuable biomarker for envisaging a satisfactory prognosis in patients with breast tumours, particularly those with luminal and basal B types, all stages and grade III tumours.PMID:35559406 | PMC:PMC9091085
Source: American Journal of Translational Research - Category: Research Authors: Source Type: research